Literature DB >> 31355397

Dual bioresponsive antibiotic and quorum sensing inhibitor combination nanoparticles for treatment of Pseudomonas aeruginosa biofilms in vitro and ex vivo.

Nishant Singh1, Manuel Romero, Alessandra Travanut, Patricia F Monteiro, Elena Jordana-Lluch, Kim R Hardie, Paul Williams, Morgan R Alexander, Cameron Alexander.   

Abstract

Many debilitating infections result from persistent microbial biofilms that do not respond to conventional antibiotic regimens. A potential method to treat such chronic infections is to combine agents which interfere with bacterial biofilm development together with an antibiotic in a single formulation. Here, we explore the use of a new bioresponsive polymer formulation derived from specifically modified alginate nanoparticles (NPs) in order to deliver ciprofloxacin (CIP) in combination with the quorum sensing inhibitor (QSI) 3-amino-7-chloro-2-nonylquinazolin-4(3H)-one (ACNQ) to mature Pseudomonas aeruginosa biofilms. The alginate NPs were engineered to incorporate a pH-responsive linker between the polysaccharide backbone and the QSI, and to encapsulate CIP via charge-charge interactions of the positively-charged drug with the carboxyl residues of the alginate matrix. In this way, a dual-action release of antibiotic and QSI was designed for the low-pH regions of a biofilm, involving cleavage of the QSI-linker to the alginate matrix and reduced charge-charge interactions between CIP and the polysaccharide as the alginate carboxyl side-chains protonated. When tested in a biofilm model the concomitant release of CIP + QSI from the pH-responsive nanoparticles significantly reduced the viability of the biofilm compared with CIP treatment alone. In addition, the alginate NPs were shown to penetrate deeply into P. aeruginosa biofilms, which we attribute in part to the charges of the NPs and the release of the QSI agent. Finally, we tested the formulation in both a 2D keratinocyte and a 3D ex vivo skin infection model. The dual-action bio-responsive QSI and CIP release nanoparticles effectively cleared the infection in the latter, suggesting considerable promise for combination therapeutics which prevent biofilm formation as well as effectively killing mature P. aeruginosa biofilms.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31355397     DOI: 10.1039/c9bm00773c

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  7 in total

1.  A Simple Polymicrobial Biofilm Keratinocyte Colonization Model for Exploring Interactions Between Commensals, Pathogens and Antimicrobials.

Authors:  Elena Jordana-Lluch; Vanina Garcia; Alexander D H Kingdon; Nishant Singh; Cameron Alexander; Paul Williams; Kim R Hardie
Journal:  Front Microbiol       Date:  2020-02-26       Impact factor: 5.640

2.  Biofilm Responsive Zwitterionic Antimicrobial Nanoparticles to Treat Cutaneous Infection.

Authors:  Sybil Obuobi; Anna Ngoc Phung; Kjersti Julin; Mona Johannessen; Nataša Škalko-Basnet
Journal:  Biomacromolecules       Date:  2021-12-16       Impact factor: 6.988

Review 3.  The Antibiofilm Nanosystems for Improved Infection Inhibition of Microbes in Skin.

Authors:  Yin-Ku Lin; Shih-Chun Yang; Ching-Yun Hsu; Jui-Tai Sung; Jia-You Fang
Journal:  Molecules       Date:  2021-10-22       Impact factor: 4.411

Review 4.  Combination Therapies for Biofilm Inhibition and Eradication: A Comparative Review of Laboratory and Preclinical Studies.

Authors:  Sophia Hawas; Anthony D Verderosa; Makrina Totsika
Journal:  Front Cell Infect Microbiol       Date:  2022-02-25       Impact factor: 5.293

5.  Attenuation of Pseudomonas aeruginosa Quorum Sensing Virulence of Biofilm and Pyocyanin by mBTL-Loaded Calcium Alginate Nanoparticles.

Authors:  Esra Kamal Eltayb; Fulwah Yahya Alqahtani; Hamad M Alkahtani; Ibrahim A Alsarra; Rihaf Alfaraj; Fadilah Sfouq Aleanizy
Journal:  Polymers (Basel)       Date:  2022-09-02       Impact factor: 4.967

Review 6.  High-Throughput Approaches for the Identification of Pseudomonas aeruginosa Antivirulents.

Authors:  Donghoon Kang; Liyang Zhang; Natalia V Kirienko
Journal:  mBio       Date:  2021-05-04       Impact factor: 7.867

7. 

Authors:  Korbin H J West; Curran G Gahan; Patricia R Kierski; Diego F Calderon; Ke Zhao; Charles J Czuprynski; Jonathan F McAnulty; David M Lynn; Helen E Blackwell
Journal:  Angew Chem Int Ed Engl       Date:  2022-03-25       Impact factor: 16.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.